key articles
Chronic treatment with a type 5 phosphodiesterase inhibitor in a rat diabetic erectile dysfunction model
Thursday, 13 March 2008 - Park et al. (2008) examined whether chronic treatment with a type 5 phosphodiesterase inhibitor (PDE5I) could suppress corporal apoptosis via potentiation of Akt signalling in diabetic erectile...
Authors: Park et al.
Erectile dysfunction and sleep related disorders
Thursday, 6 March 2008 - Oral medications are used to treat erectile dysfunction (ED) regardless of the cause of the problem and some are refractory or fail to respond as anticipated. Sleep disorder is reportedly associated with...
Authors: Jankowski et al.
Sexual function and quality of life in the male partner of infertile couples: prevalence and correlates of dysfunction
Friday, 29 February 2008 - A male factor alone or in conjunction with a female factor counts up to half of infertility cases. Male partners of infertile couples report significantly worse sexual function compared to fertile...
Authors: Shindel et al.
Adverse influence of daily vardenafil for 6 months?
Thursday, 28 February 2008 - Phosphodiesterase type 5 inhibitors are the first choice therapy in the treatment of erectile dysfunction. Many men in their reproductive years are now using phosphodiesterase type 5 inhibitors....
Authors: Jarvi et al.
Salvage of sildenafil failures with bremelanotide (PT-141)
Thursday, 28 February 2008 - Safarinejad and Hosseini (2008) evaluated the safety and efficacy of intranasal bremelanotide in men with erectile dysfunction who did not respond to sildenafil.
A total of 342 married men (28 to 59...
Authors: Safarinejad et al.
Erectile dysfunction as a harbinger for increased cardiometabolic risk
Monday, 25 February 2008 - In a review paper, Billups et al. (2008) analysed the relationship between erectile dysfunction and an increased cadiometabolic risk.
In August 2003, the Minority Health Institute (MHI) convened an...
Authors: Billups et al.
Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men
Saturday, 23 February 2008 - May et al. (2007) studied age-stratified prevalence of erectile dysfunction (ED) and its comorbidities, and assessed population's knowledge, use, and general attitude towards the treatment for...
Authors: May et al.
Looking to the future for erectile dysfunction therapies - review
Friday, 22 February 2008 - The treatment of erectile dysfunction (ED) has been revolutionized during the last 2 decades with several treatment options now available. Most of these treatments are associated with high efficacy...
Authors: Hatzimouratidis & Hatzichristou
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence
Monday, 11 February 2008 - In a study, Mathers et al. (2008) tested the hypothesis that a variable dosage of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil (25, 50, 100 mg) or vardenafil (5, 10, 25 mg) determined...
Authors: Mathers et al.
Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients
Saturday, 9 February 2008 - Historically, survival is the key criterion for prostate cancer patients treated by radical retropubic prostatectomy(RRP). However, men with newly diagnosed prostate cancer are greatly influenced by...
Author: Ayyathurai et al.
